DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1ACAMPROSATE CALCIUM
02 5DICLOFENAC SODIUM
03 7DIVALPROEX SODIUM
04 2MESALAMINE
05 3MYCOPHENOLIC SODIUM
06 1NAPROXEN
07 2NAPROXEN AND ESOMEPRAZOLE MAGNESIUM
08 12PANTOPRAZOLE SODIUM
09 1POSACONAZOLE
10 7RABEPRAZOLE SODIUM
11 1VIMOVO
01 122511
02 174376
03 174394
04 174514
05 175185
06 175281
07 176822
08 176885
09 176941
10 177056
11 177058
12 177619
13 178281
14 178597
15 178790
16 178964
17 179080
18 179163
19 190062
20 190074
21 190554
22 190797
23 190970
24 191231
25 1200142
26 1200821
27 1202038
28 1202052
29 1202555
30 1202720
31 1202882
32 1203574
33 1204179
34 1204206
35 1204237
36 1204920
37 1205761
38 1208644
39 1211858
40 1214289
41 1214476
42 1216908
01 42No
ESOMEPRAZOLE MAGNESIUM; NAPROXEN
Drug : NAPROXEN AND ESOMEPRAZOLE MAGNESIUM
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 204206
Country : US
Patented : No
Drug : MYCOPHENOLIC SODIUM
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 202555
Country : US
Patented : No
Drug : PANTOPRAZOLE SODIUM
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 90797
Country : US
Patented : No
Drug : DIVALPROEX SODIUM
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 79080
Country : US
Patented : No
Drug : DICLOFENAC SODIUM
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 74514
Country : US
Patented : No
Drug : RABEPRAZOLE SODIUM
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 208644
Country : US
Patented : No
Drug : RABEPRAZOLE SODIUM
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 204179
Country : US
Patented : No
Drug : DICLOFENAC SODIUM
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 75281
Country : US
Patented : No
Drug : DIVALPROEX SODIUM
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 90062
Country : US
Patented : No
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Drug : RABEPRAZOLE SODIUM
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 76885
Country : US
Patented : No
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LOOKING FOR A SUPPLIER?